Drug Shortage Report for UROCIT-K

Last updated on 2022-02-23 History
Report ID 151911
Drug Identification Number 02353997
Brand name UROCIT-K
Common or Proper name Potassium Citrate Extended Release Tablets
Company Name MISSION PHARMACAL COMPANY
Market Status MARKETED
Active Ingredient(s) POTASSIUM CITRATE
Strength(s) 1080MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100-ct
ATC code A12BA
ATC description POTASSIUM
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-12-24
Actual start date 2021-12-22
Estimated end date 2022-02-15
Actual end date 2022-02-22
Shortage status Resolved
Updated date 2022-02-23
Company comments Delay from label supplier.
Health Canada comments
Tier 3 Status No
Contact Address 10999 IH 10 WEST
SAN ANTONIO, TEXAS
UNITED STATES 78230-1355
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-12-28 English Compare
v2 2021-12-28 French Compare
v3 2022-01-03 English Compare
v4 2022-01-03 French Compare
v5 2022-01-31 English Compare
v6 2022-01-31 French Compare
v7 2022-02-22 English Compare
v8 2022-02-22 French Compare
v9 2022-02-23 English Compare

Showing 1 to 9 of 9